Reuters logo
BRIEF-GlaxoSmithKline's HIV medicine Tivicay approved in the European Union
January 21, 2014 / 11:56 AM / 4 years ago

BRIEF-GlaxoSmithKline's HIV medicine Tivicay approved in the European Union

Jan 21 (Reuters) - GlaxoSmithKline Plc : * VIIV Healthcare’s new HIV medicine Tivicay Tm (Dolutegravir) is approved in Europe * European commission has approved Tivicaytm for treatment of HIV infected adults, adolescents above 12 years * European regulatory authorisation to market the medicine in each member state of the European union * Source text for Eikon: * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below